Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 2.24%965.32M | 0.94%622.2M | -0.83%301.28M | -1.02%1.3B | -3.91%944.2M | -6.38%616.42M | -6.78%303.8M | -22.25%1.32B | -22.28%982.6M | -15.26%658.4M |
| Refunds of taxes and levies | 176.29%593.33K | 142.48%502.71K | --76.24K | -88.52%64.54K | -59.54%214.75K | -59.02%207.32K | ---- | -85.55%562.22K | -78.79%530.78K | -76.26%505.89K |
| Cash received relating to other operating activities | 167.70%67.1M | 130.44%41.5M | 187.13%29.64M | -53.12%22.04M | -51.12%25.07M | -51.27%18.01M | -25.67%10.32M | -4.64%47M | 38.52%51.28M | 80.31%36.96M |
| Adjustment items of operating cash inflws | ---- | ---- | ---- | ---0.01 | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from operating activities | 6.55%1.03B | 4.66%664.2M | 5.37%330.99M | -2.85%1.33B | -6.28%969.48M | -8.80%634.64M | -7.55%314.12M | -21.90%1.36B | -20.67%1.03B | -12.98%695.87M |
| Goods services cash paid | 17.78%587.69M | 29.49%393.88M | 19.77%178.62M | -17.43%681.59M | -24.28%498.95M | -25.62%304.17M | -16.80%149.13M | -20.73%825.45M | -23.44%658.93M | -36.42%408.96M |
| Staff behalf paid | 6.44%149.18M | 6.69%101.4M | 7.77%55.26M | 4.54%186.77M | 4.68%140.16M | 3.34%95.04M | 2.57%51.27M | 9.01%178.66M | 12.72%133.9M | 12.92%91.96M |
| All taxes paid | 28.87%65.13M | 31.41%48.95M | 15.37%20.7M | -24.92%69.78M | -21.79%50.54M | -19.40%37.25M | -10.71%17.95M | 18.15%92.94M | 13.57%64.62M | 88.05%46.22M |
| Cash paid relating to other operating activities | -28.99%46.01M | -34.53%29.14M | -11.35%14.35M | -3.82%93.43M | -13.39%64.8M | -17.00%44.51M | -26.80%16.18M | -30.89%97.14M | -29.34%74.82M | 7.44%53.63M |
| Cash outflows from operating activities | 12.40%848.01M | 19.21%573.37M | 14.66%268.93M | -13.62%1.03B | -19.07%754.45M | -19.94%480.98M | -13.60%234.54M | -16.16%1.19B | -18.38%932.27M | -24.82%600.77M |
| Net cash flows from operating activities | -13.97%185M | -40.89%90.83M | -22.02%62.06M | 72.77%293.77M | 110.55%215.03M | 61.58%153.66M | 16.44%79.58M | -47.25%170.04M | -36.82%102.13M | 18,967.37%95.1M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -10.22%649.58M | -18.16%478.67M | -29.57%279.59M | 57.51%865.99M | 85.88%723.49M | 187.52%584.87M | 100.43%396.99M | -58.06%549.81M | -46.60%389.23M | -60.41%203.42M |
| Cash received from returns on investments | -6.90%2.1M | 2.94%1.85M | 3.80%1.22M | -15.61%3.26M | -34.02%2.25M | -21.44%1.8M | -48.06%1.17M | 32.88%3.86M | 25.25%3.41M | -14.75%2.29M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 2,914.37%13.38M | 2,809.14%9.49M | 4,792.25%5.56M | 395.85%4.07M | 5.61%443.79K | 11.60%326.16K | 6.88%113.55K | -71.05%820.95K | 72.32%420.23K | 140.56%292.27K |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.25M | --1.25M |
| Cash inflows from investing activities | -8.42%665.06M | -16.52%490.02M | -28.10%286.37M | 57.50%873.32M | 84.17%726.18M | 183.23%587M | 97.48%398.28M | -57.89%554.49M | -46.13%394.3M | -59.89%207.25M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -13.79%166.74M | -4.32%121.4M | -1.35%43.1M | 12.08%263.98M | -5.50%193.42M | 2.59%126.88M | -48.78%43.69M | 2.28%235.53M | 20.15%204.69M | 2.03%123.67M |
| Cash paid to acquire investments | -3.56%740.86M | -28.52%444.81M | -58.76%205.94M | 47.49%966.68M | 48.95%768.21M | 74.56%622.27M | 85.30%499.37M | -48.17%655.4M | -25.13%515.77M | -22.30%356.47M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | -97.75%633.9K | ---- | ---- | ---- | -77.64%28.23M | ---- | ---- |
| Cash outflows from investing activities | -5.62%907.6M | -24.42%566.21M | -54.14%249.04M | 33.96%1.23B | 33.48%961.63M | 56.03%749.15M | 53.07%543.06M | -43.30%919.17M | -17.40%720.46M | -17.21%480.14M |
| Net cash flows from investing activities | -3.01%-242.54M | 53.01%-76.2M | 125.78%37.32M | 1.84%-357.97M | 27.81%-235.45M | 40.58%-162.15M | 5.44%-144.78M | -19.83%-364.68M | -132.39%-326.15M | -331.00%-272.89M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | 119.26%12.57M | 2,962.50%12.25M | 2,962.50%12.25M | ---- | 2.40%5.73M | -92.86%400K | -80.00%400K |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | 3,043.30%12.57M | 2,962.50%12.25M | 2,962.50%12.25M | ---- | -92.86%400K | -92.86%400K | -80.00%400K |
| Cash from borrowing | 443.66%157.66M | 244.83%100M | 2,900.00%60M | -89.88%30M | -90.15%29M | -89.03%29M | -94.92%2M | 7.76%296.33M | 59.10%294.33M | 60.20%264.33M |
| Cash received relating to other financing activities | ---- | ---- | ---- | -96.06%25.76M | -100.67%-4.42M | -100.68%-4.42M | ---- | 6,630.50%654.29M | 7,707.80%659.46M | --654.78M |
| Cash inflows from financing activities | 328.12%157.66M | 171.54%100M | 2,900.00%60M | -92.85%68.34M | -96.14%36.83M | -96.00%36.83M | -99.71%2M | 229.41%956.35M | 379.38%954.19M | 450.61%919.51M |
| Borrowing repayment | 86.19%37.8M | 73.99%34.8M | --1M | -80.26%54.54M | -92.53%20.3M | -88.36%20M | ---- | 199.46%276.25M | 2,370.45%271.75M | 1,461.36%171.75M |
| Dividend interest payment | 17.80%81.3M | 35.59%7.4M | 38.37%5.13M | 30.04%72.08M | 27.58%69.02M | 30.84%5.46M | 61.05%3.71M | 13.43%55.43M | 16.37%54.1M | -90.61%4.17M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | --0 | ---- | --1.96M | ---- | ---- | ---- | ---- | ---- |
| Cash payments relating to other financing activities | 17.58%11.02M | 83.34%8.52M | -7.64%2.46M | -31.46%21.88M | 16.45%9.37M | 55.51%4.65M | 40.55%2.66M | -44.23%31.93M | -73.24%8.05M | -72.92%2.99M |
| Cash outflows from financing activities | 31.85%130.12M | 68.47%50.72M | 34.82%8.59M | -59.16%148.5M | -70.44%98.69M | -83.17%30.11M | 51.79%6.37M | 83.30%363.6M | 281.34%333.89M | 169.14%178.91M |
| Net cash flows from financing activities | 144.53%27.55M | 633.40%49.28M | 1,276.48%51.41M | -113.52%-80.16M | -109.97%-61.86M | -99.09%6.72M | -100.64%-4.37M | 544.60%592.75M | 456.38%620.3M | 636.74%740.6M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -112.71%-4.36M | -232.20%-1.49M | -278.97%-313.68K | 172.43%5.12M | -202.67%-2.05M | -56.59%1.12M | 107.95%175.27K | -85.73%1.88M | -86.73%2M | -51.31%2.59M |
| Net increase in cash and cash equivalents | 59.25%-34.36M | 9,817.04%62.42M | 316.87%150.48M | -134.81%-139.24M | -121.17%-84.33M | -100.11%-642.41K | -111.73%-69.39M | 224.89%399.99M | 169.39%398.28M | 1,214.13%565.39M |
| Add:Begin period cash and cash equivalents | -16.82%688.56M | -16.82%688.56M | -16.82%688.56M | 93.50%827.8M | 93.50%827.8M | 93.50%827.8M | 84.72%827.8M | 40.41%427.81M | 40.41%427.81M | 40.41%427.81M |
| End period cash equivalent | -12.01%654.2M | -9.21%750.98M | 10.63%839.04M | -16.82%688.56M | -10.00%743.46M | -16.72%827.15M | -27.05%758.41M | 93.50%827.8M | 82.55%826.08M | 185.64%993.2M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | -- | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.